11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →

Join Veristat and over 500 attendees from the local biopharmaceutical industry at this year’s Outsourcing in Clinical Trials New England show in Boston, MA. The conference theme is discovering new strategies for operational challenges during clinical trials such as patient centricity, sites and trial design.
This years’ agenda contains innovative sessions and fascinating content including a regulatory workshop for medical devices, a patient recruitment panel from past and current patients and an interactive debate focusing on outsourcing vs. procurement. A sampling of topics include:
Veristat can help you manage your entire clinical trial, starting with program design, regulatory agency engagement and study start-up activities. We will identify and qualify the top sites for patient recruitment success. Our oversight continues with clinical operations and biometrics services through to regulatory submissions support and agency representation. We have teams on the ground throughout North America, Europe and Australia to support your programs.
11 min read
Oct 21, 2026 Veristat Blog
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...